SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

PepeCoin is a meme token based on the character Pepe the Frog. Initially launched in March 2016 on its own blockchain, it later migrated to Ethereum. PepeCoin is recognized as the original Pepe currency due to its long history.   The project aims to provide a variety of use cases, transforming PepeCoin into a memecoin with utility.  The community is primarily focused on creating a fun atmosphere, actively engaging in various events to enhance the token's growth and visibility. Additionally, PepeCoin is developing a game that will serve as an interactive social Web 3.0 video game platform, further expanding its ecosystem and fostering interaction among users.

PepeCoin

PepeCoin is trending as its dedicated community fervently asserts it as the 'original' Pepe token, emphasizing its foundational status and robust utility compared to the $PEPE meme coin, which they label an imposter. The coin's deflationary, mineable nature, coupled with its role in the expanding BasedAI ecosystem and the anticipated Kekspace launch, is driving conviction for massive upside from its currently low market cap.

Green Thumb Industries, Inc. engages in the manufacture and distribution of branded cannabis products. Its brands include RYTHM, Dogwalkers, Beboe, Good Green, Doctor Solomon’s, and &Shine. It operates through the Retail and Consumer Packaged Goods segments. The Retail segment focuses on retailing cannabis to patients and consumers. The Consumer Packaged Goods segment refers to the cultivation, production, and sale of cannabis products to retail stores. The company was founded by Benjamin Kovler and Max Cohen on February 18, 2002 and is headquartered in Chicago, IL.

Green Thumb Industries Inc - Ordinary Shares (Sub Voting)

Green Thumb Industries

Green Thumb Industries (GTBIF) is trending as the community eagerly anticipates federal cannabis rescheduling to Schedule III, a move expected to eliminate the restrictive 280E tax burden and significantly boost profitability for this "best in class" multi-state operator, drawing increased attention to the "severely undervalued" sector.

The Aircoin memecoin was born from a viral Twitter post from March, 2014 which proclaimed the following:   Evolution: 1. Aircoin 2. Fartcoin 3. Artcoin  Aircoin was launched in August, 2025 and CTO'd twice, with the second CTO team bringing vast experience and expertise to the project. The team includes industry veterans and visual arts professionals.  Aircoin is destined for greatness as a premier memecoin on the BONK.fun platform.

aircoin

AIRCOIN is trending as its innovative "Airlock" mechanism has led to over 40% of its supply being locked by the community, generating strong bullish sentiment around unique supply control and reduced selling pressure. This meme coin on the Solana ecosystem is also highlighted for its USD1 paired liquidity pool and ambitious goal of being listed on every major exchange, with community members emphasizing its resilience and "anti-rug" potential.

Trulieve Cannabis Corp. engages in the provision of medical cannabis products and services. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Quincy, FL.

Trulieve Cannabis Corp - Ordinary Shares (Sub Voting)

Trulieve Cannabis

Trulieve Cannabis is seeing significant discussion as the market anticipates federal cannabis rescheduling to Schedule III, a critical move expected to eliminate burdensome 280E taxes and attract substantial institutional investment for U.S. multi-state operators. Concurrently, the community is closely following developments surrounding Florida's recreational legalization ballot, viewed as a major potential catalyst for Trulieve's leading market position despite perceived political challenges.

MiNK Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of allogeneic invariant natural killer T cell therapies to treat cancer and other immune mediated diseases. The company was founded in 2017 and is headquartered in New York, NY.

MiNK Therapeutics Inc

MiNK Therapeutics is generating buzz as recent data presentations highlight its iNKT cell therapy's potential in Idiopathic Pulmonary Fibrosis and a peer-reviewed article on CAR-iNKT cells for solid tumors. This is sparking community enthusiasm over a reported complete remission in advanced testicular cancer and speculated collaborations with ImmunityBio, while also stirring debates about potential dilution versus strategic partnerships.

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

ZIM is trending following Hapag-Lloyd's official $35 per share cash acquisition announcement, driving fervent community discussions around potential short squeezes and arbitrage while grappling with significant uncertainty over Israeli government approval due to national security and the company's strategic importance.

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Boston Scientific Corp.

Boston Scientific's shares are trending lower after its Q4 earnings report, despite beating estimates, primarily due to cautious 2026 guidance and the near-term earnings dilution from its recent large acquisition of Penumbra. The community is actively debating whether this significant dip represents a buying opportunity for the medical device leader.

Moo Deng

MOODENG Crypto is trending with significant bullish momentum, reflecting a recent surge and strong community conviction for an imminent breakout to higher levels. Traders are actively discussing technical patterns like higher lows and double bottoms, fueling speculative interest and FOMO among those seeking rapid gains.

Globalstar, Inc. engages in the provision of mobile satellite services. It offers voice and data communications services to the following markets: recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, natural resources, mining, and forestry, construction, utilities, and transportation. The company was founded in November 2003 and is headquartered in Covington, LA.

Globalstar Inc.

Globalstar is trending amid escalating speculation of a potential acquisition by major tech players like SpaceX or Amazon, driven by its uniquely valuable n53 spectrum and crucial role in Apple's future direct-to-device services. The community is eagerly awaiting key FCC decisions on spectrum use and C-3 constellation approval, which are seen as critical catalysts alongside the growing adoption of Globalstar's XCOM RAN for private 5G networks and drone command and control.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas Semiconductor is trending following the unveiling of its highly efficient GaN and SiC power platforms, which are crucial for next-generation AI data centers and grid infrastructure. While the community recognizes the immense potential in solving the AI sector's escalating power demands, a primary concern revolves around the absence of announced definitive, revenue-generating contracts from major industry players.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Equities Analysts Set Expectations for CRDL FY2025 Earnings

Cardiol Therapeutics Inc. (NASDAQ:CRDL - Free Report) - Research analysts at Brookline Cap M issued their FY2025 EPS estimates for shares of Cardiol Therapeutics in a note issued to investors on...

Cardiol Therapeutics (NASDAQ:CRDL) Stock Rating Upgraded by Brookline Cap M

Brookline Cap M upgraded shares of Cardiol Therapeutics to a "strong-buy" rating in a research report on Tuesday...

Analysts Offer Predictions for CRDL FY2025 Earnings

Cardiol Therapeutics Inc. (NASDAQ:CRDL - Free Report) - Stock analysts at Brookline Capital Management issued their FY2025 earnings per share estimates for Cardiol Therapeutics in a research report...

Cardiol Therapeutics (TSE:CRDL) Shares Down 7.1% - Time to Sell?

Cardiol Therapeutics (TSE:CRDL) Shares Down 7.1% - Here's What Happened...

Cardiol Therapeutics (TSE:CRDL) Shares Down 7.1% - What's Next?

Cardiol Therapeutics (TSE:CRDL) Trading Down 7.1% - What's Next...

Cardiol Therapeutics (NASDAQ:CRDL) Raised to Strong-Buy at Brookline Capital Management

Brookline Capital Management upgraded shares of Cardiol Therapeutics to a "strong-buy" rating in a research note on Tuesday...

Cardiol Therapeutics (TSE:CRDL) Stock Price Up 1.5% - Still a Buy?

Cardiol Therapeutics (TSE:CRDL) Trading 1.5% Higher - What's Next...

Cardiol Therapeutics (TSE:CRDL) Stock Price Down 0.7% - Here's Why

Cardiol Therapeutics (TSE:CRDL) Trading Down 0.7% - Here's What Happened...

Cardiol Therapeutics Inc. (NASDAQ:CRDL) Given Average Recommendation of "Buy" by Brokerages

Shares of Cardiol Therapeutics Inc. (NASDAQ:CRDL - Get Free Report) have received a consensus rating of "Buy" from the five research firms that are covering the stock, MarketBeat reports. One...

Cardiol Therapeutics (NASDAQ:CRDL) Receives "Buy" Rating from HC Wainwright

HC Wainwright reiterated a "buy" rating and set a $9.00 price objective on shares of Cardiol Therapeutics in a report on Monday...

Cardiol Therapeutics, Inc. is a clinical-stage life sciences company focused on the research and clinical of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Its lead product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. The firm is conducting clinical studies to evaluate the efficacy and safety of CardiolRx in diseases affecting the heart: a Phase II multi-national, randomized, double-blind, placebo-controlled trial (the ARCHER trial) in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis. It is also involved in developing a novel subcutaneously administered drug formulation of cannabidiol intended for use in heart failure. The company was founded by David Elsley, Eldon Smith, and Anthony Bolton on January 19, 2017 and is headquartered in Oakville, Canada.

Cardiol Therapeutics Inc - Ordinary Shares - Class A

3%+ above current levels

Up 0–3%

Flat to down 3%

Down 3%+

The Nasdaq 100 continues to hinge on mega-cap tech and AI strength. With rate expectations shifting and valuations stretched, even a 3% move could signal a bigger trend. Is momentum building, or fading?

CRDL
Cardiol Therapeutics Inc - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest CRDL News

CRDLCardiol Therapeutics Inc - Ordinary Shares - Class A